Harsha Girdhar Gopal, MD
Otolaryngology · Chestnut Hill, MANPI 1225143027
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.7%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intersect ENT, Inc. at 50.7% of the total. Reporting peaked in 2019 at $2,682 and has fallen 87.8% since, to $327 in 2025.
Across 37 payments — averaging $133.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$3K
- Stryker$2K
- Aerin Medical Inc.$537
- Medtronic$101
- Smith+Nephew$68
- Neurent Medical Limited$50
- plus $135 from 4 others
What the payments were for
- Travel & lodging$2,55552%
- Food & beverage$2,23945%
- Entertainment$1453%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 10 | $2,505 |
| Stryker | 9 | $1,545 |
| Aerin Medical Inc. | 4 | $537 |
| Medtronic(2 entities) | 4 | $101 |
| Smith+Nephew | 3 | $68 |
| Neurent Medical Limited | 2 | $50 |
| Optinose US, Inc. | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Sanofi | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$2,152
- ENTELLUS - XPRESS ENT DILATION SYSTEM$1,081
- PROPEL$298
- VIVAER STYLUS$239
- RHINAER STYLUS$239
- LATERA$178
- CLARIFIX CRYOTHERAPY DEVICE$178
- Vivaer RF Stylus$133
How this compares
$4,939 in reported general payments places this provider in the 85th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide | 64 | $11,119 |
| Ipratropium Bromide | 113 | $4,358 |
| Omeprazole | 205 | $3,062 |
| Mometasone Furoate | 31 | $2,911 |
| Fluticasone Propionate | 131 | $2,740 |
| Azelastine Hcl | 84 | $1,963 |
| Famotidine | 80 | $734 |
| Mupirocin | 42 | $260 |
| Montelukast Sodium | 11 | $255 |
| Fluocinolone Acetonide Oil | 12 | $232 |
| Clarithromycin | 13 | $224 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $216 |
| Azithromycin | 22 | $90 |
| Prednisone | 14 | $23 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Chestnut Hill
- Ayesha KhalidConcord$511K
- Dennis PoeBoston$264K
- Peter WeberBoston$157K
- Kevin EmerickBoston$89K
- Benjamin BleierBoston$77K
- Gregory RandolphBoston$56K
- Daniel LeeBoston$52K
- Pratik PradhanBrockton$51K
- Marika RussellBoston$50K
- Natalia KyriazidisQuincy$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.